How to Master Biopharma Business?
The biopharmaceutical industry is not just the future of medicine — it’s the epicenter of innovation, investment, and global growth. To truly... Read More
A case based understanding in co-development deal
Posted on21 Feb 2024
Comments0
In a Co-Development Agreement the intellectual property is typically licensed by the licensor to the alliance partner, and as well, the two... Read More
Indication splitting in biopharma licensing
While licensing in bio pharmaceutical business, if licenses are issued to different partners based on indications or disease and therapy, then this... Read More
What is difference between 351(a) vs. 351(k) pathway?
the terms 351(a) pathway and 351(k) pathway are typically associated with the approval of biological products, particularly in the context of the... Read More
What is difference between co-promotion and co-marketing deal in pharma?
Posted on17 Oct 2023
Tagsbiopharma business, Biopharma business development, comarketing, copromotion, inlicensing, Outlicensing, Pharma Business
Comments0
With co-marketing you have the same product, but different brands. With co-promotion, there is only 1 brand, but 2 different sales forces.... Read More